Article Versions Notes

Cheng Y-H, Chen K-H, Sung Y-T, Yang C-C, Chien C-T. Intrarenal Arterial Transplantation of Dexmedetomidine Preconditioning Adipose Stem-Cell-Derived Microvesicles Confers Further Therapeutic Potential to Attenuate Renal Ischemia/Reperfusion Injury through miR-122-5p/Erythropoietin/Apoptosis Axis. Antioxidants. 2022; 11(9):1702. https://doi.org/10.3390/antiox11091702

Cheng, Yu-Hsuan, Kuo-Hsin Chen, Yi-Ting Sung, Chih-Ching Yang, and Chiang-Ting Chien. 2022. "Intrarenal Arterial Transplantation of Dexmedetomidine Preconditioning Adipose Stem-Cell-Derived Microvesicles Confers Further Therapeutic Potential to Attenuate Renal Ischemia/Reperfusion Injury through miR-122-5p/Erythropoietin/Apoptosis Axis" Antioxidants 11, no. 9: 1702. https://doi.org/10.3390/antiox11091702

Cheng, Y.-H., Chen, K.-H., Sung, Y.-T., Yang, C.-C., & Chien, C.-T. (2022). Intrarenal Arterial Transplantation of Dexmedetomidine Preconditioning Adipose Stem-Cell-Derived Microvesicles Confers Further Therapeutic Potential to Attenuate Renal Ischemia/Reperfusion Injury through miR-122-5p/Erythropoietin/Apoptosis Axis. Antioxidants, 11(9), 1702. https://doi.org/10.3390/antiox11091702